Published in Diabetologia on June 01, 1994
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis (2007) 2.76
Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009) 2.46
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) (2010) 2.25
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol (2009) 2.22
Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes. Diabetes Care (2011) 1.96
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol (2008) 1.72
Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes (2007) 1.68
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol (2011) 1.67
Vitamin D and immune function. Nutrients (2013) 1.57
Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology (2008) 1.45
Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis. Menopause (2012) 1.42
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev (2016) 1.25
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol (2009) 1.13
Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol (2000) 1.10
Minireview: Vitamin D: is there a role in extraskeletal health? Endocrinology (2011) 1.05
Vitamin D and diabetes. Endocrinol Metab Clin North Am (2013) 1.03
Autoimmune Addison disease: pathophysiology and genetic complexity. Nat Rev Endocrinol (2012) 1.00
Vitamin D and multiple sclerosis. J Cell Biochem (2008) 0.99
Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. Am J Epidemiol (2013) 0.95
Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol (2008) 0.94
Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One (2009) 0.92
Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol (2008) 0.92
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91
Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet. Clin Exp Immunol (2007) 0.91
Vitamin D and its emerging role in immunopathology. Clin Rheumatol (2011) 0.89
On the Wegener granulomatosis associated region on chromosome 6p21.3. BMC Med Genet (2006) 0.88
Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87
Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun (2009) 0.86
Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res Ther (2014) 0.85
Death pathways in T cell homeostasis and their role in autoimmune diabetes. Rev Diabet Stud (2006) 0.85
1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol (1998) 0.85
Rising incidence and challenges of childhood diabetes. A mini review. J Endocrinol Invest (2012) 0.84
Low levels of 25-hydroxyvitamin D in the pediatric populations: prevalence and clinical outcomes. Ped Health (2010) 0.83
The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. Int J Endocrinol (2013) 0.83
Seasonal variation of vitamin D and HbA(1c) levels in patients with type 1 diabetes mellitus in the Middle East. Int J Gen Med (2011) 0.83
A Nonsecosteroidal Vitamin D Receptor Modulator Ameliorates Experimental Autoimmune Encephalomyelitis without Causing Hypercalcemia. Autoimmune Dis (2011) 0.83
Stay tuned to PXR: an orphan actor that may not be D-structive only to bone. J Clin Invest (2005) 0.82
Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice. Endocrinology (2011) 0.81
Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells. Hum Vaccin Immunother (2013) 0.81
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3. Clin Exp Immunol (2002) 0.81
Gestational and Early Infancy Exposure to Margarine Fortified with Vitamin D through a National Danish Programme and the Risk of Type 1 Diabetes: The D-Tect Study. PLoS One (2015) 0.79
The beneficial role of vitamin D in systemic lupus erythematosus (SLE). Clin Rheumatol (2012) 0.79
Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function. PLoS One (2015) 0.78
Vitamin D at the onset of type 1 diabetes in Italian children. Eur J Pediatr (2013) 0.77
Serum vitamin D status in children and adolescence with diabetes according to season and age. Ann Pediatr Endocrinol Metab (2014) 0.77
Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons. Islets (2013) 0.76
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol (2017) 0.75
Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. PLoS One (2013) 0.75
Type-specific human papillomavirus detection in cervical smears in Romania. APMIS (2010) 0.75
Low serum vitamin-D status is associated with high prevalence and early onset of type-1 diabetes mellitus in Kuwaiti children. BMC Pediatr (2016) 0.75
Skin-derived TSLP systemically expands regulatory T cells. J Autoimmun (2017) 0.75
Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?). Clin Exp Immunol (2016) 0.75
Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes. Rev Diabet Stud (2012) 0.75
The Vitamin D Receptor Regulates Tissue Resident Macrophage Response to Injury. Endocrinology (2016) 0.75
A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes. Endocr Connect (2017) 0.75
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine (1999) 9.70
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods (2001) 6.68
Vitamin D and diabetes. Diabetologia (2005) 3.58
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest (1981) 3.15
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med (1990) 2.67
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A (2001) 2.42
The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech (2003) 2.30
Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet (1990) 2.04
Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol (1982) 1.87
Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem (1980) 1.80
The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab (1977) 1.73
The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril (1992) 1.65
Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology (1992) 1.62
Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide. Clin Endocrinol (Oxf) (1998) 1.43
Maintenance and reversibility of natural killer cell- and T cell-independent B lymphocyte xenotolerance in athymic nude rats. Transplantation (1999) 1.41
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. Gerontology (1996) 1.39
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab (1997) 1.38
Diabetic bone disease. Calcif Tissue Int (1991) 1.35
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis (1988) 1.30
1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes (1992) 1.30
Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab (1998) 1.30
Measurement of 25-hydroxyvitamin D3 in serum. Clin Chem (1976) 1.28
Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab (1995) 1.24
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res (2003) 1.22
1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes (2000) 1.20
Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem (1980) 1.19
Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes (1990) 1.17
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest (1997) 1.17
Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity. Q J Med (1985) 1.16
Coexistence of hypocalciuric hypercalcaemia and interstitial lung disease in a family: a cross-sectional study. Eur J Clin Invest (1985) 1.16
Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs. Curr Med Chem (2007) 1.15
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol (1998) 1.15
In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res (2001) 1.14
Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril (1991) 1.13
Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women. Front Horm Res (1975) 1.13
C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol (1993) 1.13
The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem (1976) 1.13
Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med (1997) 1.12
25-hydroxyvitamin D and its binding protein in maternal and cord serum. J Clin Endocrinol Metab (1977) 1.12
Etiology of hypercalcemia in a patient with Addison's disease. Calcif Tissue Int (1982) 1.12
Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res (1999) 1.12
Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol (2000) 1.10
Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology (1992) 1.10
Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1980) 1.10
The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab (1975) 1.10
25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab (2014) 1.10
Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr (1994) 1.09
The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol (1992) 1.08
Effect of a presumed consent law on organ retrieval in Belgium. Transplant Proc (1990) 1.07
Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency. J Bone Miner Res (2000) 1.07
Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb (1992) 1.06
Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology (1995) 1.06
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int (2012) 1.05
Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol (1995) 1.05
Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J Neuroimmunol (1995) 1.03
Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet (2000) 1.03
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin (2008) 1.02
A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem (1980) 1.02
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃. Best Pract Res Clin Endocrinol Metab (2011) 1.02
Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur J Clin Invest (1998) 1.02
Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J Invest Dermatol (1997) 1.01
p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J Biol Chem (2000) 1.01
The role of the plasminogen system in bone resorption in vitro. J Bone Miner Res (1999) 1.00
Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab (1984) 1.00
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab (1997) 1.00
The isolation and characterization of the vitamin D-binding protein from rat serum. J Biol Chem (1978) 0.99
Space flight: a challenge for normal bone homeostasis. Crit Rev Eukaryot Gene Expr (2001) 0.99
Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology (1997) 0.98
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab (2001) 0.98
Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia (1986) 0.98
Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology (1989) 0.98
Characteristics of the vitamin D binding protein in different species. Calcif Tissue Res (1976) 0.98
Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology (1998) 0.97
Gene expression related to the differentiation of osteoblastic cells is altered by microgravity. Bone (1998) 0.97
Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. Biochem Biophys Res Commun (2001) 0.96
Three years of experience with a 'presumed consent' legislation in Belgium: its impact on multi-organ donation in comparison with other European countries. The Leuven Collaborative Group for Transplantation. Transplant Proc (1991) 0.95
Vitamin D metabolism in breast-fed infants and their mothers. Pediatr Res (1989) 0.95
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab (1998) 0.95
Xenotransplantation: where are we in 2008? Kidney Int (2008) 0.95
Increased bone formation in mice lacking plasminogen activators. J Bone Miner Res (2003) 0.95